Molecular Pharmacology (USA), Ltd.
MLPH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 6/30/2014 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $117 |
| SG&A Expenses | $6 | $13 | $8 | $117 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $13 | $8 | $117 |
| Operating Income | -$6 | -$13 | -$8 | -$117 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$888 | $0 | $0 |
| Pre-Tax Income | -$6 | -$901 | -$8 | -$117 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$901 | -$8 | -$117 |
| % Margin | – | – | – | – |
| EPS | 0 | -0.001 | -0 | -0.001 |
| % Growth | 100% | -800% | 90% | – |
| EPS Diluted | 0 | -0.001 | -0 | -0.001 |
| Weighted Avg Shares Out | 999,554 | 999,554 | 111,554 | 111,554 |
| Weighted Avg Shares Out Dil | 999,554 | 999,554 | 111,554 | 111,554 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$901 | -$8 | -$117 |
| % Margin | – | – | – | – |